Amedica Announces Filing of Key Patent Application Relating to the Anti-Viral Effect of its Silicon Nitride
SALT LAKE CITY, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride for biomedical applications, today announced the filing of a U.S. patent application for breakthrough research findings that have identified a new property of its proprietary silicon nitride. Amedica investigators led by Dr. Giuseppe Pezzotti,